Shanghai Genbase Biotechnology

This profile synthesizes all available information about Shanghai Genbase Biotechnology, confirming it is an active private Chinese biotech specializing in innovative immunotherapies—including autologous CAR‑T/TCR‑T therapies and monoclonal antibodies—for oncology indications such as solid tumors and gastric cancer. It operates under the umbrella of Jikai Gene Medicine, collaborates closely with Genechem, maintains a modest employee base (<100), has no public trading symbol or major international partnerships yet reported, but demonstrates robust early-stage R&D activity supported by publications and patents within its field.